Q32 Bio (QTTB) EBIAT (2018 - 2025)
Historic EBIAT for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.
- Q32 Bio's EBIAT rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 3054.4%. This contributed to the annual value of -$47.7 million for FY2024, which is 1118.29% up from last year.
- Latest data reveals that Q32 Bio reported EBIAT of -$7.4 million as of Q3 2025, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
- Q32 Bio's 5-year EBIAT high stood at $92.1 million for Q1 2022, and its period low was -$34.3 million during Q4 2022.
- For the 5-year period, Q32 Bio's EBIAT averaged around -$12.1 million, with its median value being -$14.2 million (2024).
- In the last 5 years, Q32 Bio's EBIAT surged by 868387.7% in 2022 and then tumbled by 117201.17% in 2025.
- Over the past 5 years, Q32 Bio's EBIAT (Quarter) stood at -$33.6 million in 2021, then decreased by 2.12% to -$34.3 million in 2022, then rose by 21.08% to -$27.1 million in 2023, then skyrocketed by 47.58% to -$14.2 million in 2024, then skyrocketed by 47.92% to -$7.4 million in 2025.
- Its last three reported values are -$7.4 million in Q3 2025, -$9.5 million for Q2 2025, and -$11.0 million during Q1 2025.